Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125540341 | 12554034 | 1 | I | 20160705 | 20160713 | 20160713 | EXP | AU-PURDUE-USA-2016-0132063 | PURDUE | PLASEK, THOMAS M., ET. AL. SERIOUS ADVERSE DRUG REACTIONS TO ZOLPIDEM: DOES IMPAIRED METABOLIC CLEARANCE ANDCONCURRENT SSRI/SNRI USE INCREASE RISK?. JOURNAL OF PHARMACY PRACTICE AND RESEARCH. 2016;46:139-142 | 64.00 | YR | M | Y | 0.00000 | 20160713 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125540341 | 12554034 | 1 | PS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | U | UNKNOWN | 22328 | |||||||||
| 125540341 | 12554034 | 2 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 3 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 4 | SS | WARFARIN | WARFARIN | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 5 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 6 | SS | TEMAZEPAM. | TEMAZEPAM | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 7 | SS | TETRACYCLINE | TETRACYCLINE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 8 | SS | PENICILLIN /00000901/ | PENICILLIN G | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 9 | SS | PRAZOSIN | PRAZOSIN | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 10 | SS | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 11 | SS | RABEPRAZOLE | RABEPRAZOLE | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 125540341 | 12554034 | 12 | SS | DEXTROPROPOXYPHENE | PROPOXYPHENE HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125540341 | 12554034 | 1 | Depression |
| 125540341 | 12554034 | 2 | Product used for unknown indication |
| 125540341 | 12554034 | 3 | Product used for unknown indication |
| 125540341 | 12554034 | 4 | Product used for unknown indication |
| 125540341 | 12554034 | 5 | Product used for unknown indication |
| 125540341 | 12554034 | 6 | Product used for unknown indication |
| 125540341 | 12554034 | 7 | Product used for unknown indication |
| 125540341 | 12554034 | 8 | Product used for unknown indication |
| 125540341 | 12554034 | 9 | Product used for unknown indication |
| 125540341 | 12554034 | 10 | Product used for unknown indication |
| 125540341 | 12554034 | 11 | Product used for unknown indication |
| 125540341 | 12554034 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125540341 | 12554034 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125540341 | 12554034 | Fall | |
| 125540341 | 12554034 | Somnambulism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |